For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
ADHD: Pharmacotherapy lowers mortality
Wednesday 26 February 2025, 12:38 AM

[Image: Tara Winstead on Pexels]
Goodfellow Gems #234
A cohort study in Sweden identified individuals aged 6 to 64 years with an incident diagnosis of attention deficit hyperactivity disorder from 2007 th
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Li L, Zhu N, Zhang L, et al. ADHD pharmacotherapy and mortality in individuals with ADHD. JAMA 2024;331(10):850–60.